Pursuant to the Loan Agreement, the Borrower’s obligations under the Loan Agreement are secured by the Borrower’s assets and Holdings’ equity interests in the Borrower, including all distributions, proceeds and profits from Holdings’ interests in the Borrower.
In connection with the Loan Agreement, the Company entered into a Guaranty (the “Guaranty”) among the Company, Exantas Real Estate Funding 2018-RS06 Investor, LLC (“RS06”), Exantas Real Estate Funding 2019-RS07 Investor, LLC (“RS07”), and Exantas Real Estate Funding 2020-RS08 Investor, LLC (“RS08”, and collectively with RS06 and RS07, the “Additional Subsidiaries”), each an indirect, wholly owned subsidiary of the Company, in favor of the secured parties under the Loan Agreement. Pursuant to the Guaranty, the Company fully guaranteed all payments and performance of Holdings and the Borrower under the Loan Agreement. Additionally, the Company and the Additional Subsidiaries made certain representations and warranties and agreed to not incur debt or liens, each subject to certain exceptions, and agreed to provide the Lenders with certain information.
The Loan Agreement contains events of default, subject to certain materiality thresholds and grace periods, customary for this type of financing arrangement, including but not limited to, bankruptcy or insolvency proceedings, a change of control of Holdings, the Borrower or the Company, breaches of covenants and/or representations and warranties, performance defaults, or a judgment in an amount greater than $5,000,000 against Holdings or the Borrower. The remedies for such events of default are also customary for this type of transaction and include the acceleration of the principal amount outstanding under the Loan Agreement and liquidation of the assets securing the Facility.
The foregoing descriptions of the Loan Agreement and the Guaranty are only summaries, do not purport to be complete and are qualified in their entirety by reference to the full text of the Loan Agreement and the Guaranty, which are filed as Exhibit 10.2 and Exhibit 10.3 hereto and are incorporated herein by reference.
12% Senior Notes Due 2027 and Warrants
On July 31, 2020, the Company entered into a Note and Warrant Purchase Agreement (the “Note and Warrant Purchase Agreement”) with Oaktree and MassMutual pursuant to which the Company may issue to Oaktree and MassMutual from time to time up to $125 million aggregate principal amount of 12% senior unsecured notes due 2027 (the “Senior Notes”) and warrants (the “Warrants”) to purchase an aggregate of up to 3.5 million shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), at an exercise price of $0.01 per share (subject to certain potential adjustments), for an aggregate cash purchase price of up to $125 million. The Senior Notes have an annual interest rate of 12.00%, payable up to 3.25% (at the election of the Company) as pay-in-kind interest and the remainder as cash interest. On July 31, 2020, the Company issued to Oaktree $42.0 million aggregate principal amount of the Senior Notes and warrants to purchase 1,176,000 shares of the Common Stock for an aggregate purchase price of $42.0 million. In addition, on July 31, 2020, the Company issued to MassMutual $8.0 million aggregate principal amount of the Senior Notes and warrants to purchase 224,000 shares of the Common Stock for an aggregate purchase price of $8.0 million. At any time and from time to time prior to January 31, 2022, the Company may elect to issue to Oaktree and MassMutual up to $75 million aggregate principal amount of additional Senior Notes and warrants to purchase an additional 2.1 million shares of the Common Stock for a purchase price equal to the principal amount of the additional Senior Notes being issued.
The Note and Warrant Purchase Agreement contains events of default, subject to certain materiality thresholds and grace periods, customary for this type of financing arrangement, including but not limited to, bankruptcy or insolvency proceedings, breaches of covenants and/or representations and warranties, performance defaults, or a judgement in an amount greater than $25,000,000 (exclusive of insurance proceeds). The remedies for such events of default are also customary for this type of transaction and include the acceleration of all Notes then outstanding under the Note and Warrant Purchase Agreement.
The foregoing description of the Note and Warrant Purchase Agreement is only a summary, does not purport to be complete and is qualified in its entirety by reference to the full text of the Note and Warrant Purchase Agreement, including the terms of the Form of Note and Form of Warrant attached as exhibits thereto, which is filed as Exhibit 10.4 hereto and is incorporated herein by reference.
Promissory Note
On July 31, 2020, RCC Real Estate, Inc., a direct, wholly owned subsidiary of the Company, provided a $12 million loan (the “ACRES Loan”) to ACRES Capital Corp. evidenced by a Promissory Note (the “Promissory Note”) from ACRES Capital Corp.